I. Takemoto

Secretory transport of irinotecan metabolite SN-38 across isolated intestinal tissue

K. Iseki, S. Itagaki, T. Hirano, 2005, Cancer Chemotherapy and Pharmacology.

Characterization of secretory intestinal transport of the lactone form of CPT-11

K. Iseki, S. Itagaki, T. Hirano, 2005, Cancer Chemotherapy and Pharmacology.

Biliary excretion of irinotecan and its metabolites.

K. Sasaki, K. Iseki, S. Itagaki, 2004, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2

K. Iseki, S. Itagaki, T. Hirano, 2005, Cancer Chemotherapy and Pharmacology.

Pharmacokinetic modulation of irinotecan metabolites by sulphobromophthalein in rats

K. Sasaki, K. Iseki, S. Itagaki, 2004, The Journal of pharmacy and pharmacology.

Disribution of Irinotecan to Pleural and Pericardial Fluids in Patients with Lung Cancer

K. Sasaki, K. Iseki, T. Hirano, 2002 .

Development of System for Managing Medicines Brought to Hospital by Inpatients and Role of Hospital Pharmacists in It

Y. Fukuda, Tomoko Suzuki, T. Itoh, 2008 .